|
Vaccine Detail
S. pneumoniae GtS Protein Vaccine |
Vaccine Information |
- Vaccine Name: S. pneumoniae GtS Protein Vaccine
- Target Pathogen: Streptococcus pneumoniae
- Target Disease: Pneumonia
- Vaccine Ontology ID: VO_0004068
- Type: Subunit vaccine
- Status: Research
- Antigen: recombinant (r) Glutamyl tRNA synthetase (GtS) (Mizrachi et al., 2007).
- GltX
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Adjuvant:
- Immunization Route: Intraperitoneal injection (i.p.)
|
Host Response |
Mouse Response
- Host Strain: BALB/c OlaHsd
- Vaccination Protocol: Mice were immunized intraperitoneally with 25 μg of rGtS and 75 μL of Imject Alum adjuvant on days 0 and 21. Control mice were sham immunized with adjuvant only (Mizrachi et al., 2007).
- Challenge Protocol: For lethal respiratory challenge with S. pneumoniae, rGtSâimmunized and control mice were anesthetized with isoflurane and inoculated intranasally with S. pneumoniae serotype 3 strain WU2 (in 25 μL of PBS). The size of this inoculum was found to be the lowest that causes 100% mortality in control mice within 96 h. Survival was monitored daily (Mizrachi et al., 2007).
- Efficacy: Thirty-nine percent of rGtS-immunized mice survived a lethal bacterial challenge, whereas no control mice survived (Mizrachi et al., 2007).
|
References |
Mizrachi et al., 2007: Mizrachi Nebenzahl Y, Bernstein A, Portnoi M, Shagan M, Rom S, Porgador A, Dagan R. Streptococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice. The Journal of infectious diseases. 2007; 196(6); 945-953. [PubMed: 17703427].
|
|